Endogenous assessment of late gadolinium enhancement grey area in patients with chronic myocardial infarction using T1rho mapping

利用T1ρ映射技术对慢性心肌梗死患者晚期钆增强灰区进行内源性评估

阅读:2

Abstract

BACKGROUND: The grey area in myocardial infarction (MI) patients is crucial for prognosis. T1rho mapping is a promising magnetic resonance imaging (MRI) technique for ischemic cardiomyopathy. This study aims to investigate the feasibility of T1rho in evaluating the tissue characteristics of the grey area adjacent to the infarcted myocardium. METHODS: A total of 40 chronic MI patients with positive late gadolinium enhancement (LGE) and 23 healthy controls were enrolled in the study. For the MI patients, the myocardium was divided into the LGE core [5 standard deviation (SD) above remote myocardium], grey area (2-5 SD above remote myocardium), and remote myocardium based on LGE signal intensity. We compared the native T1, T1rho, and extracellular volume (ECV) values among different myocardial regions in MI patients and healthy controls and assessed their diagnostic performance in identifying grey areas. RESULTS: The native T1, T1rho, and ECV values were significantly different across the four myocardium categories (LGE core, grey area, remote area, and healthy controls, P<0.001). Pairwise analysis showed significant differences in these parameters between the grey and remote areas (native T1: 1,341.34±57.27 vs. 1,264.79±46.42 ms; T1rho: 53.47±4.83 vs. 44.26±2.68 ms; ECV: 36.95%±5.66% vs. 28.03%±1.87%, all P<0.05). Receiver operating characteristic (ROC) analysis indicated that T1rho was a more effective discriminator between the LGE grey area and the remote area of patients [area under the curve (AUC): 0.985 vs. 0.863 and 0.982] compared to native T1 and ECV, with its Youden index reaching 0.921. CONCLUSIONS: T1rho mapping presents a viable tool for detecting fibrosis of a grey area in chronic MI patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。